Boc-N-Et-Leu-OH · DCHA

Boc-N-Et-Leu-OH · DCHA is a Boc-protected leucine derivative bearing an N-ethyl substituent, supplied as a dicyclohexylamine (DCHA) salt form that improves handling and solid-state characteristics for synthetic workflows. The combination of a Boc-protected amino terminus with a substituted nitrogen and a protected carboxylic acid functionality makes this building block particularly useful for preparing defined peptide segments and amino acid derivatives where controlled coupling and downstream deprotection are required.

1. Peptide Segment Coupling

Boc-N-Et-Leu-OH · DCHA is used by peptide synthesis groups to assemble leucine-containing peptide segments with an N-ethylated amino functionality, enabling the preparation of peptides and peptidomimetic analogs that require altered backbone substitution patterns. In custom peptide manufacturing and academic peptide chemistry, this reagent supports reliable segment condensation workflows where the Boc group provides an orthogonal handle for stepwise assembly and the salt form supports consistent reagent handling during coupling and purification.

2. Peptidomimetic Building Block

Boc-N-Et-Leu-OH · DCHA serves as a targeted amino acid building block for peptidomimetic development, where modifying the N-substitution state is used to tune properties such as conformational preferences and chemical stability in synthetic analogs. Medicinal chemistry teams and chemical biology researchers incorporate this derivative into larger scaffold syntheses to produce well-defined N-substituted peptide analogs for structure-activity relationship studies, SAR libraries, and mechanistic probe development that rely on precise stereochemical and substitution control.

3. Pharmaceutical Intermediate Development

Boc-N-Et-Leu-OH · DCHA is frequently selected in pharmaceutical intermediate development for the preparation of N-substituted leucine derivatives and protected amino acid intermediates used downstream in multi-step synthesis. Process chemists and intermediate manufacturers value the Boc-protected, salt-form presentation for improving operational consistency across batch preparations, enabling efficient progression from amino acid building block procurement to the next protected intermediate stage used in complex molecule assembly.

4. Solid-Phase Peptide Synthesis

Boc-N-Et-Leu-OH · DCHA is also used in solid-phase peptide synthesis workflows when a leucine residue with an N-ethyl substitution pattern is required in the final sequence. Peptide synthesis laboratories rely on the Boc-protected amino functionality to integrate this building block into stepwise chain elongation strategies while maintaining control over protecting-group behavior, supporting the preparation of defined N-substituted peptide products for screening, characterization, and analytical method development.

1. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII

2. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma

3. High fat diet and GLP-1 drugs induce pancreatic injury in mice

4. A possible role of tachykinin-related peptide on an immune system activity of mealworm beetle, Tenebrio molitor L

5. Emu oil in combination with other active ingredients for treating skin imperfections